Taipei Exchange - Delayed Quote TWD

EirGenix Inc. (6589.TWO)

Compare
79.80
+0.80
+(1.01%)
At close: 1:30:18 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,170,886.00
1,022,653.00
1,481,017.00
1,697,359.00
1,071,838.00
Cost of Revenue
891,550.00
785,912.00
724,565.00
604,305.00
321,171.00
Gross Profit
279,336.00
236,741.00
756,452.00
1,093,054.00
750,667.00
Operating Expense
1,313,570.00
1,268,718.00
1,087,663.00
1,150,676.00
1,736,671.00
Operating Income
-1,034,234.00
-1,031,977.00
-331,211.00
-57,622.00
-986,004.00
Net Non Operating Interest Income Expense
132,943.00
124,068.00
49,945.00
-10,783.00
-25,407.00
Pretax Income
-984,969.00
-913,650.00
-114,315.00
-41,165.00
-1,041,323.00
Tax Provision
1,724.00
1,558.00
1,225.00
1,416.00
347.00
Net Income Common Stockholders
-986,693.00
-915,208.00
-115,540.00
-42,581.00
-1,041,670.00
Diluted NI Available to Com Stockholders
-986,693.00
-915,208.00
-115,540.00
-42,581.00
-1,041,670.00
Basic EPS
-3.23
-3.00
-0.38
-0.18
-5.41
Diluted EPS
-3.23
-3.00
-0.38
-0.18
-5.41
Basic Average Shares
305,419.60
304,888.00
303,258.00
242,662.00
202,247.00
Diluted Average Shares
305,711.23
304,888.00
303,258.00
242,662.00
202,247.00
Total Expenses
2,205,120.00
2,054,630.00
1,812,228.00
1,754,981.00
2,057,842.00
Net Income from Continuing & Discontinued Operation
-986,693.00
-915,208.00
-115,540.00
-42,581.00
-1,041,670.00
Normalized Income
-934,777.80
-915,208.00
-115,853.60
-42,029.80
-1,041,670.00
Interest Income
140,400.00
134,471.00
59,584.00
10,366.00
3,093.00
Interest Expense
7,457.00
10,403.00
9,639.00
21,149.00
28,500.00
Net Interest Income
132,943.00
124,068.00
49,945.00
-10,783.00
-25,407.00
EBIT
-977,512.00
-903,247.00
-104,676.00
-20,016.00
-1,012,823.00
EBITDA
-688,902.00
-664,407.00
100,608.00
164,980.00
-840,670.00
Reconciled Cost of Revenue
891,550.00
785,912.00
724,565.00
604,305.00
321,171.00
Reconciled Depreciation
288,610.00
238,840.00
205,284.00
184,996.00
172,153.00
Net Income from Continuing Operation Net Minority Interest
-986,693.00
-915,208.00
-115,540.00
-42,581.00
-1,041,670.00
Total Unusual Items Excluding Goodwill
-64,894.00
--
392.00
-689.00
--
Total Unusual Items
-64,894.00
--
392.00
-689.00
--
Normalized EBITDA
-624,008.00
-664,407.00
100,216.00
165,669.00
-840,670.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-12,978.80
--
78.40
-137.80
--
12/31/2020 - 11/23/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4162.TWO PharmaEngine, Inc.
95.10
+2.15%
 
4743.TWO Oneness Biotech Co., Ltd.
79.70
+1.66%
 
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%
 
6547.TWO Medigen Vaccine Biologics Corporation
47.60
-3.94%
 
6535.TWO Lumosa Therapeutics Co., Ltd.
263.50
-0.57%
 
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
 
4174.TWO OBI Pharma, Inc.
56.90
+1.25%
 
6550.TW Polaris Group
43.40
+0.46%
 
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
 
4142.TW Adimmune Corporation
22.60
-1.74%